IRCT20200411047029N1已完成3 期
Evaluation of the effectiveness of PHR-160 spray in recovery of hospitalized patients with Covid-19 in Isfahan province in 1399
The Research Institute of Food and Secrets TAAMASRAR0 个研究点目标入组 198 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 198
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age more than 18 years
- •Definite diagnosis of SARS-CoV-2 virus based on PCR
- •Diagnosis of pneumonia consistent with lung involvement with COVID-19 on CT scan
- •Need to be admitted to the ICU at the beginning of hospitalization
排除标准
- •Having comorbidities (chronic kidney failure, cirrhosis, severe heart failure (less than 25% EF), active or untreated cancer)
- •Pregnancy and breastfeeding
- •Patients with hepatic enzymes including aspartate transaminase (AST) and alanine transaminase (ALT) at 5 times more than normal amount
研究者
相似试验
招募中
1 期
Evaluation of the effectiveness of PHR-160 spray in hospitalized patients with Covid-19IRCT20201223049816N1Bagheiat-allah University of Medical Sciences240
招募中
3 期
Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19IRCT20200731048257N1Bagheiat-allah University of Medical Sciences224
已完成
3 期
Evaluation of PHR160 spray effect on improvement of severe asthmatic patients.IRCT20220610055122N1Ahvaz University of Medical Sciences60
Unknown
不适用
Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19COVID-19NCT04463420Baqiyatallah Medical Sciences University224
尚未招募
2 期
Evaluation of the efficacy and safety of PR/HC/1718/001 in knee osteoarthritis.CTRI/2019/05/019179Aayush Healthcare